Favipiravir: PMS study finds no concerns with the usage, mild side effects detected–here’s why it…
A total number of 1,083 patients took part in the multicenter, open-label single-arm study and the study showed no concerns with the usage of Favipiravir (Photo: Reuters)Glenmark Pharmaceuticals, a global integrated pharmaceutical company,…